Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB-WT) EBIT Margin (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed EBIT Margin for 2 consecutive years, with 81.3% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 86323.0% to 81.3% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 338.72% through Dec 2025, up 718861.0% year-over-year, with the annual reading at 338.72% for FY2025, 718861.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 81.3% at Nuvation Bio, up from 430.14% in the prior quarter.
  • The five-year high for EBIT Margin was 81.3% in Q4 2025, with the low at 32779.44% in Q2 2024.